Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | BA3021 |
Trade Name | |
Synonyms | CAB-ROR2-ADC|BA 3021 |
Drug Descriptions |
BA3021 (CAB-ROR2-ADC) is a conditionally active anti-ROR2 antibody in conjugation with a cytotoxic agent that preferentially binds and delivers cytotoxicity to Ror2-expressing cells in tumors, therefore exhibits anti-tumor activity (Proceedings of the AACR, Apr 2018, Vol 59, Abstract 833). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C155812 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BA3021 | BA3021 | 0 | 1 |